Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
Background and Objectives: During the pandemic of COVID-19, additional blood donor eligibility criteria have been added to ensure safety of donors and donations. The aim of this study is to estimate the seroprevalence of SARS-CoV-2 antibody in eligible donors and to study the demography and lifesty...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2021-07-01
|
| Series: | Dubai Medical Journal |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/517456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846096099082764288 |
|---|---|
| author | May Raouf Mariem Rabeh Suminder Kaur Ranjita Sharma Nimmy Thottumkal Roukaya Mohammed |
| author_facet | May Raouf Mariem Rabeh Suminder Kaur Ranjita Sharma Nimmy Thottumkal Roukaya Mohammed |
| author_sort | May Raouf |
| collection | DOAJ |
| description | Background and Objectives: During the pandemic of COVID-19, additional blood donor eligibility criteria have been added to ensure safety of donors and donations. The aim of this study is to estimate the seroprevalence of SARS-CoV-2 antibody in eligible donors and to study the demography and lifestyle of asymptomatic cases. Materials and Methods: One thousand four hundred eighteen eligible donors were enrolled in this study in the Dubai Blood Donation Center from August to December 2020. Blood samples were tested for SARS-CoV-2 antibody. Donors’ demographic characteristics and lifestyle were studied further. The χ2 test was used to analyze the data association. Results: 88.4% of the studied group were males, 85% were from age 17 to 45 years, and 53% were regular donors. The seroprevalence of SARS-CoV-2 antibody was 13.5% and significantly related to gender, frequency of donation, collection site, type of donation, and more frequent when donors shared transport and accommodation. Blood group and age had no significant association. 5.5% were found to have cough/fever or a history of contact with positive COVID-19 patients. Conclusions: The seroprevalence of SARS-CoV-2 antibody was 13.5% among eligible blood donors, and hence the current eligibility criteria allow asymptomatic COVID-19 patients to donate blood. The seroprevalence was seen more in first time donors, suggesting that regular blood donors are safer. Additional risk factors related to lifestyle can be identified to ensure safety of transfusion during COVID-19 pandemic. |
| format | Article |
| id | doaj-art-cb598069bd404d51842b66f005e2c08c |
| institution | Kabale University |
| issn | 2571-726X |
| language | English |
| publishDate | 2021-07-01 |
| publisher | Knowledge E |
| record_format | Article |
| series | Dubai Medical Journal |
| spelling | doaj-art-cb598069bd404d51842b66f005e2c08c2025-01-02T08:17:21ZengKnowledge EDubai Medical Journal2571-726X2021-07-011810.1159/000517456517456Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk FactorsMay Raoufhttps://orcid.org/0000-0001-6615-3470Mariem RabehSuminder KaurRanjita SharmaNimmy ThottumkalRoukaya MohammedBackground and Objectives: During the pandemic of COVID-19, additional blood donor eligibility criteria have been added to ensure safety of donors and donations. The aim of this study is to estimate the seroprevalence of SARS-CoV-2 antibody in eligible donors and to study the demography and lifestyle of asymptomatic cases. Materials and Methods: One thousand four hundred eighteen eligible donors were enrolled in this study in the Dubai Blood Donation Center from August to December 2020. Blood samples were tested for SARS-CoV-2 antibody. Donors’ demographic characteristics and lifestyle were studied further. The χ2 test was used to analyze the data association. Results: 88.4% of the studied group were males, 85% were from age 17 to 45 years, and 53% were regular donors. The seroprevalence of SARS-CoV-2 antibody was 13.5% and significantly related to gender, frequency of donation, collection site, type of donation, and more frequent when donors shared transport and accommodation. Blood group and age had no significant association. 5.5% were found to have cough/fever or a history of contact with positive COVID-19 patients. Conclusions: The seroprevalence of SARS-CoV-2 antibody was 13.5% among eligible blood donors, and hence the current eligibility criteria allow asymptomatic COVID-19 patients to donate blood. The seroprevalence was seen more in first time donors, suggesting that regular blood donors are safer. Additional risk factors related to lifestyle can be identified to ensure safety of transfusion during COVID-19 pandemic.https://www.karger.com/Article/FullText/517456sars-cov-2 antibodydonor eligibilitydonor demographylifestyle |
| spellingShingle | May Raouf Mariem Rabeh Suminder Kaur Ranjita Sharma Nimmy Thottumkal Roukaya Mohammed Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors Dubai Medical Journal sars-cov-2 antibody donor eligibility donor demography lifestyle |
| title | Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors |
| title_full | Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors |
| title_fullStr | Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors |
| title_full_unstemmed | Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors |
| title_short | Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors |
| title_sort | seroprevalence of igg anti sars cov 2 among voluntary blood donors in dubai demographic and risk factors |
| topic | sars-cov-2 antibody donor eligibility donor demography lifestyle |
| url | https://www.karger.com/Article/FullText/517456 |
| work_keys_str_mv | AT mayraouf seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors AT mariemrabeh seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors AT suminderkaur seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors AT ranjitasharma seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors AT nimmythottumkal seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors AT roukayamohammed seroprevalenceofiggantisarscov2amongvoluntaryblooddonorsindubaidemographicandriskfactors |